- Quantitative trait loci
- Sib pairs
- Statistical power
Objectives: In sib pair studies, quantitative trait loci (QTL) identification may be adversely affected by non-normality in the phenotypic distribution, particularly when subjects falling in the tails of the distribution bias the trait mean or variance. We evaluated the robustness and power of reducing the influence of subjects with extreme phenotypic values by Winsorizing non-normal distributions in three versions of Haseman-Elston regression-based methods of QTL linkage analysis. Methods: Data were simulated for normal and non-normal distributions. Phenotypic values that correspond to cutoff points at the ω and 1 – ω percentiles of the distribution were identified, and phenotypic values falling outside the boundaries of the ω and 1 – ω cutoff points were replaced by the ω and 1 – ω values, respectively. One million replications were performed for the three tests of linkage for Winsorized and non-Winsorized data. Results: Winsorization reduced conservatism in the tails of the empirical type I error rate for the vast majority of the tests of linkage, increased the power of QTL detection in non-normal data and created a slight negative bias in symmetrical phenotypic distributions. Conclusions: Winsorizing can improve the power of QTL detection with certain non-normal distributions but can also introduce bias into the estimate of the QTL effect.
Copyright © 2002 S. Karger AG, Basel
- Amos CI: Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet 1994;54:535–543.
- Amos CI, Zhu DK, Boerwinkle E: Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet 1996;60:143–160.
- Amos CI, Krushkal J, Thiel TJ, Young A, Zhu DK, Boerwinkle E, de Andrade M: Comparison of model-free linkage mapping strategies for the study of a complex trait. Genet Epidemiol 1997;14:743–748.
- Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198–1211.
- Fulker DW, Cherny SS: An improved multipoint sib pair analysis of quantitative traits. Behav Genet 1996;26:527–532.
- Schork NJ: Extended pedigree patterned covariance matrix mixed models for quantitative phenotype analysis. Genet Epidemiol 1992;9:73–86.
- Schork NJ: Extended multipoint identity-by-descent analysis of human quantitative traits: Efficiency, power, and modeling considerations. Am J Hum Genet 1993;53:1306–1319.
- Wijsman EM, Amos CI: Genetic analysis of simulated oligogenic traits in nuclear and extended pedigrees: Summary of GAW10 contributions. Genet Epidemiol 1997;14:719–735.
- Kruglyak L, Lander ES: A nonparametric approach for mapping quantitative trait loci. Genetics 1995;139:1421–1428.
- Whittemore AS, Tu IP: Simple, robust linkage tests for affected sibs. Am J Hum Genet 1998;62:1228–1242.
- Risch N, Zhang H: Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995;268:1584–1589.
- Risch N, Zhang H: Mapping quantitative trait loci with extreme discordant sib pairs: Sampling considerations. Am J Hum Genet 1996;58:836–843.
- Haseman JK, Elston RC: The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 1972;2:1584–1589.
- Blackwelder WC, Elston RC: Power and robustness of sib pair linkage tests and extension to larger sibships. Commun Stat Theory Methods 1982;11:449–484.
- Wang J, Guerra R, Cohen J: Statistically robust approaches for sib pair linkage analysis. Ann Hum Genet 1998;62:349–359.
- Elston RC, Buxbaum S, Jacobs KB, Olson JM: Haseman and Elston revisited. Genet Epidemiol 2000;19:1–17.
- Allison DB, Fernández JR, Heo M, Beasley MT: Testing the robustness of the new Haseman-Elston quantitative-trait loci mapping procedure. Am J Hum Genet 2000;67:249–252.
- Elston RC, Shete S: Adding further power to the Haseman and Elston’s (1972) method. GeneScreen 2000;1:63–64.
- Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J: Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet 1999;65:531–544.
- Wilcox RR: Introduction to Robust Estimation and Hypothesis Testing. San Diego, Academic Press, 1997, pp 18–29.
- Sawilowsky SS, Blair R: A more realistic look at the robustness and type II error properties of the t test to departures from population normality. Psychol Bull 1992;111:352–360.
- Evans M, Hastings N, Peacock B: Laplace distribution; in Evans M, Hastings N, Peacock B (eds): Statistical Distributions. New York, Wiley, 1993, pp 92–94.
- SAS Release 7.0. Cary, SAS Institute, 1998.
Dr. José R. Fernàndez
Division of Physiology and Metabolism
Department of Nutrition Sciences, University of Alabama at Birmingham
Webb 435 – 1530 3rd Avenue S, Birmingham, AL 35294-3360 (USA)
Tel. +1 205 934 2029, Fax +1 205 934 7050, E-Mail email@example.com
Received: Received: September 28, 2001
Revision received: December 18, 2001
Accepted: December 20, 2001
Number of Print Pages : 9
Number of Figures : 2, Number of Tables : 6, Number of References : 23
Human Heredity (International Journal of Human and Medical Genetics)
Founded 1950 as Acta Genetica et Statistica Medica by Gunnar Dahlberg; Continued by M. Hauge (1965–1983)
Vol. 53, No. 2, Year 2002 (Cover Date: Released May 2002)
Journal Editor: J. Ott, New York, N.Y.
ISSN: 0001–5652 (print), 1423–0062 (Online)
For additional information: http://www.karger.ch/journals/hhe
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.